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Abstract The direct three-component condensation of 6-
aminouracil, 6-amino-2-thiouracil or 6-amino-1,3-
dimethyluracil, with arylaldehydes and malononitrile to
generate a series of pyrido[2,3-d]pyrimidine derivatives
has been carried out over nanocrystalline MgO with high
efficiency in water as a green solvent at 80 C. The mor-
phology and structure of the nanocrystalline MgO were
characterized by scanning electron microscopy, transmis-
sion electron microscopy and X-ray diffraction. The results
confirmed the nanocrystalline MgO particle size is ap-
proximately 50 nm. This methodology offers significant
improvements for the synthesis of pyrido[2,3-d]pyrimidine
derivatives with regard to the yield of products, simplicity
in operation, and green aspects by avoiding toxic catalysts
and solvents.
Keywords Aminouracils  Pyrido[2,3-d]pyrimidines 
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Background
MgO is a particularly interesting material, since it has
been the subject of extensive theoretical and experimental
surface science studies. It exhibits optical properties and
architectures and can be synthesized in a variety of
presentation formats, including nanosheets and nanopar-
ticles [1]. Nano-MgO particles are attractive catalysts
because of the large surface area they present. Nanoca-
talysts are considered to be a bridge between homoge-
neous and heterogeneous catalyst [2, 3]. Pyrido[2,3-
d]pyrimidines are annulated uracil which have received
considerable attention over the past years due to their
wide range of biological and pharmacological activities
such as antitumor [4], antihypertensive and hepatopro-
tective [5], cardiotonic [6] and antifolate [7]. Uracil
derivatives are versatile building blocks for the synthesis
of nitrogen-containing heteroaromatic species of biological
importance [8]. Pyrazolopyridines [9], pyramidopyrimidines
[10], pyridopurines [11], pyrazolopyrimidines [12] and
xanthine derivatives [13] have all been prepared by the
functionalization of uracil derivatives. The diverse range
of biological activities of uracil derivatives in parasitic
chemotherapy has stimulated considerable interest in their
synthesis. Therefore, a number of reports have appeared in
the literatures such as palladium-catalyzed oxidative cou-
pling [14], nucleophilic-induced ring transformation [15],
KF–Al2O3 [16], L-proline [17], triethylbenzylammonium
chloride (TEBAC) [18], diammonium hydrogen phosphate
(DAHP) [19] and tetra-n-butyl ammonium bromide
(TBAB) [20]. Most of these reported methods require a
forcing conditions, high temperature, long reaction times
and complex synthetic pathways. Thus new routes for the
synthesis of these molecules have attracted considerable
attention in search for a rapid entry to these heterocycles.
Herein, nanocrystalline MgO has been successfully applied
to perform the reaction of 6-aminouracil, 6-amino-2-
thiouracil or 6-amino-1,3-dimethyluracil with mal-
ononitrile and aldehydes in water at 80 C to provide a
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Methods
The nanocrystallineMgOwas purchased fromTecnan Spanish
Company. The crystalline structure of the powders was in-
vestigated by X-ray diffraction (INEL Equinox) with Cu-Ka,
radiation, l = 0.1541874 A˚ radiation. The surface area of
nanocrystalline MgO was observed using N2 adsorption–des-
orption isotherms with surface analyzer equipment at 77 K.
The size and morphology of the nanocrystalline MgO were
determined using a transmission electron microscope (TEM,
Philips EM208) and a scanning electron microscope (SEM,
Philips 9l30). The NMR spectra were recorded in DMSO-d6
with TMS as an internal standard on a Bruker Avance DRX
400 MHz spectrometer. FT-IR spectra were determined on an
SP-1100, P-UV-Com instrument. The products were charac-
terized by FT-IR, 1HNMR, 13CNMR and by comparison with
authentic samples reported in the literature.
General synthesis of pyrido[2,3-d]pyrimidines
A mixture of aromatic aldehyde (1 mmol), 6-aminouracil,
6-amino-2-thiouracil or 6-amino-1,3-dimethyluracil (1 mmol)
and malononitrile (1 mmol) in the presence of nanocrystalline
MgO (0.25 mmol) was stirred in water (5 ml) at 80 C for the
appropriate time, as shown in Table 1. Completion of the re-
action was indicated by TLC monitoring. The nanocrystalline
MgO was filtered off and the reaction mixture was cooled to
ambient temperature, and the crude solid residue was recrys-
tallized from ethanol and water to afford pure crystals of the
proper pyrido[2,3-d]pyrimidines in 84–96 % yields.




Mp[300 C. FT-IR (KBr): 3456, 3313 (NH2 stretch), 3224
(aromatic C–H stretch), 2206 (C:N stretch), 1664, 1625
(C=O stretch), 1566, 1510 (aromatic C=C stretch), 1440 (NO2
asymmetric stretch), 1363 (NO2 symmetric stretch), 1278,
1217 (symmetricC–Hbend, CH3), 838, 806, 750 (aromaticC–
Hout ofplanebending) cm-1; 1HNMR(400 MHz,CDCl3):d;
3.30 (s, 3H, CH3), 3.68 (s, 3H, CH3), 5.82 (s, 2H, NH2), 7.62
(m, 1H), 7.71 (t, J = 7.8 Hz, 1H), 8.17 (t, J = 8.1 Hz, 1H),
8.39 (m, 1H) ppm (Fig. 1); 13C NMR (100 MHz, CDCl3): d;
159.9 (C=O amide), 159.0, 157.1, 154.1, 151.0, 148.0, 137.7,
133.1, 129.5, 124.0, 122.7, 114.6 (C:N), 100.2, 89.7, 30.3




Mp [300 C. FT-IR (KBr): 3442, 3311 (NH2 stretch),
3217 (aromatic C–H stretch), 2212 (C:N stretch), 1712,
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Table 1 Synthesis of pyrido[2,3-d]pyrimidine derivatives by
nanocrystalline MgO
Entry X R Aryl Product Time (min) Yield (%)a
1 O H C6H5 4a 18 92
2 O H 2-Cl-C6H4 4b 15 89
3 O H 4-Cl-C6H4 4c 12 96
4 O H 4-MeO-C6H4 4d 30 88
5 O H 4-Me-C6H4 4e 35 87
6 O Me 3-NO2-C6H4 4f 30 90
7 O Me 4-NO2-C6H4 4g 20 95
8 O Me 4-Cl-C6H4 4h 15 90
9 O Me 3-Cl-C6H4 4i 20 86
10 O Me 2-Cl-C6H4 4j 25 84
11 O Me 3-Br-C6H4 4k 15 86
12 O Me 4-F-C6H4 4l 25 90
13 S H C6H5 4m 20 88
14 S H 4-Cl-C6H4 4n 16 90
15 S H 4-Br-C6H4 4o 15 90
16 S H 4-F-C6H4 4p 12 92
Reaction and conditions: 6-aminouracil, 6-amino-2-thiouracil or
6-amino-1,3-dimethyluracil (1 mmol), aldehyde (1 mmol), mal-
ononitrile (1 mmol) and nanocrystalline MgO (0.25 mmol) in H2O
(5 mL) at 80 C
a All yields refer to isolated products
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1444 (NO2 asymmetric stretch), 1375 (NO2 symmetric
stretch), 1272, 1224 (symmetric C–H bend, CH3), 968, 848
(aromatic C–H out of plane bending) cm-1; 1H NMR
(400 MHz, DMSO-d6): d; 3.08 (s, 3H, CH3), 3.51 (s, 3H,
CH3), 7.50 (dd, J = 6.9, 1.9 Hz, 2H), 8.00 (s, 2H, NH2),
8.31 (dd, J = 6.9, 1.9 Hz, 2H) ppm (Fig. 3); 13C NMR
(100 MHz, DMSO-d6): d; 160.1, 158.6, 157.0 (C=O
amide), 153.5, 150.8, 147.3, 144.4, 128.9, 123.0, 114.9




Mp [300 C. FT-IR (KBr): 3568, 3458 (NH2 stretch),
3216 (aromatic C–H stretch), 2214 (C:N stretch), 1714,
1714, 1654 (C=O stretch), 1622, 1566, 1515 (aromatic
C=C stretch), 1274, 1230 (symmetric C–H bend, CH3), 750
(C–Cl stretch), 700, 659 (aromatic C–H out of plane
bending) cm-1; 1H NMR (400 MHz, DMSO-d6): d; 3.09
(s, 3H, CH3), 3.51 (s, 3H, CH3), 7.28 (dd, J = 6.6, 1.8 Hz,
2H), 7.51 (dd, J = 6.6, 1.8 Hz, 2H), 7.93 (s, 2H, NH2) ppm
(Fig. 5); 13C NMR (100 MHz, DMSO-d6): d; 160.2(C=O
amide), 160.1, 158.5, 158.0, 153.6 (C=O amide), 150.8,
136.1, 132.96, 129.2, 127.9, 115.2 (C:N), 98.6, 88.3, 29.6




Mp[300 C. FT-IR (KBr): 3461, 3334 (NH2 stretch), 3228
(aromatic C–H stretch), 2219 (C:N stretch), 1712, 1672
(C=O stretch), 1637, 1508 (aromatic C=C stretch), 1276,
1224 (symmetric C–H bend, CH3), 975 (C–Cl stretch), 790,
748, 705 (aromatic C–H out of plane bending) cm-1; 1H
NMR (400 MHz, DMSO-d6): d; 3.09 (s, 3H, CH3), 3.51 (s,
3H,CH3), 7.21 (d, J = 6.8 Hz, 1H,Hc), 7.34 (s, 1H), 7.48 (m,
2H), 7.93 (s, 2H, NH2) ppm (Fig. 7);
13C NMR (100 MHz,
DMSO-d6): d; 160.2, 160.1, 158.4, 157.5 (C=O amide),
153.5, 150.8, 139.3, 132.4, 129.8, 128.0, 127.0, 126.0, 115.1




Mp [300 C. FT-IR (KBr): 3460, 3315 (NH2 stretch),
3218 (aromatic C–H stretch), 2210 (C:N stretch), 1716,
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Fig. 3 1H NMR spectra of 7-amino-1,3-dimethyl-5-(4-nitrophenyl)-2,4-dioxo-1,2,3,4-tetrahydropyrido[2,3-d]pyrimidine-6-carbonitrile
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Fig. 4 13C NMR spectra of 7-amino-1,3-dimethyl-5-(4-nitrophenyl)-2,4-dioxo-1,2,3,4-tetrahydropyrido[2,3-d]pyrimidine-6-carbonitrile
Fig. 5 1H NMR spectra of 7-amino-5-(4-chlorophenyl)-1,3-dimethyl-2,4-dioxo-1,2,3,4-tetrahydropyrido[2,3-d] pyrimidine-6-carbonitrile
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1658 (C=O stretch), 1620, 1568 (aromatic C=C stretch),
1278, 1230 (symmetric C–H bend, CH3), 748 (C–Cl
stretch), 700, 659 (aromatic C–H out of plane bending)
cm-1; 1H NMR (400 MHz, DMSO-d6): d; 3.10 (s, 3H,
CH3), 3.52 (s, 3H, CH3), 7.26 (dd, J = 7.8, 1.2 Hz, 1H),
7.44 (m, 2H), 7.55 (dd, J = 7.8, 1.2 Hz, 1H), 7.99 (s, 2H,
NH2) ppm (Fig. 9);
13C NMR (100 MHz, DMSO-d6): d;
160.4, 160.3, 158.2, 156.2 (C=O amide), 153.5, 150.7,
136.3, 130.4, 129.9, 128.8, 128.7, 127.0, 114.7 (C:N),




Mp[300 C. FT-IR (KBr): 3454, 3309 (NH2 stretch), 3213
(aromatic C–H stretch), 2210 (C:N stretch), 1712, 1662
(C=O stretch), 1623, 1554 (aromatic C=C stretch), 1434,
1365 (symmetric C–H bend, CH3), 748 (C–Br stretch) cm
-1;
1H NMR (400 MHz, CDCl3): d; 3.32 (s, 3H, CH3), 3.70 (s,
3H, CH3), 5.74 (s, 2H, NH2), 7.38 (s, 1H), 7.40 (m, 2H), 7.64
(m, 1H) ppm (Fig. 11); 13C NMR (100 MHz, CDCl3): d;
159.8 (C=O amide), 158.9, 158.3, 154.0, 151.1, 148.1, 138.1,
134.9, 132.2, 130.0, 129.9, 125.6, 122.3, 114.8 (C:N), 89.9,




Mp [300 C. FT-IR (KBr): 3469, 3319 (NH2 stretch),
3217 (aromatic C–H stretch), 2212 (C:N stretch), 1708,
1649 (C=O stretch), 1622, 1554, 1508 (aromatic C=C
stretch), 1276, 1226 (symmetric C–H bend, CH3), 973 (C–
F stretch), 850, 806, 752 (aromatic C–H out of plane
bending) cm-1; 1H NMR (400 MHz, DMSO-d6): d; 3.09
(s, 3H, CH3), 3.50 (s, 3H, CH3), 7.25 (m, 2H), 7.30 (m,
2H), 7.89 (s, 2H, NH2) ppm (Fig. 13);
13C NMR
(100 MHz, DMSO-d6): d; 163.2 (C=S), 160.8 (C=O
amide), 160.1, 159.4, 158.3, 153.6, 150.8, 133.3, 129.6,
115.3 (C:N), 114.8, 114.6, 98.7, 88.6, 88.5, 29.6 (CH3),
27.7 (CH3) ppm (Fig. 14).
Fig. 6 13C NMR spectra of 7-amino-5-(4-chlorophenyl)-1,3-dimethyl-2,4-dioxo-1,2,3,4-tetrahydropyrido[2,3-d] pyrimidine-6-carbonitrile
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Fig. 7 1H NMR spectra of 7-amino-5-(3-chlorophenyl)-1,3-dimethyl-2,4-dioxo-1,2,3,4-tetrahydropyrido[2,3-d] pyrimidine-6-carbonitrile
Fig. 8 13C NMR spectra of 7-amino-5-(3-chlorophenyl)-1,3-dimethyl-2,4-dioxo-1,2,3,4-tetrahydropyrido[2,3-d] pyrimidine-6-carbonitrile
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Fig. 9 1H NMR spectra of 7-amino-5-(2-chlorophenyl)-1,3-dimethyl-2,4-dioxo-1,2,3,4-tetrahydropyrido[2,3-d] pyrimidine-6-carbonitrile
Fig. 10 13C NMR spectra of 7-amino-5-(2-chlorophenyl)-1,3-dimethyl-2,4-dioxo-1,2,3,4-tetrahydropyrido[2,3-d] pyrimidine-6-carbonitrile
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Fig. 13 1H NMR spectra of 7-amino-5-(4-fluorophenyl)-1,3-dimethyl-2,4-dioxo-1,2,3,4-tetrahydropyrido[2,3-d] pyrimidine-6-carbonitrile
Fig. 14 13C NMR spectra of 7-amino-5-(4-fluorophenyl)-1,3-dimethyl-2,4-dioxo-1,2,3,4-tetrahydropyrido[2,3-d] pyrimidine-6-carbonitrile
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Fig. 15 1H NMR spectra of 7-amino-5-(4-fluorophenyl)-4-oxo-2-thioxo-1,2,3,4-tetrahydropyrido[2,3-d]pyrimidine-6-carbonitrile
Fig. 16 13C NMR spectra of 7-amino-5-(4-fluorophenyl)-4-oxo-2-thioxo-1,2,3,4-tetrahydropyrido[2,3-d]pyrimidine-6-carbonitrile





Mp [300 C. FT-IR (KBr): 3402, 3315, 3220 (NH
stretch), 3087 (aromatic C–H stretch), 2214 (C:N
stretch), 1695, 1623 (C=O stretch), 1585, 1546
(aromatic C=C stretch), 1192 (C=S stretch), 1076 (C–F
stretch), 802, 723 (aromatic C–H out of plane bending)
cm-1; 1H NMR (400 MHz, DMSO-d6): d; 7.26 (m,
2H), 7.35 (m, 2H), 7.81 (s, 2H, NH2), 12.19 (s, 1H,
NH), 12.84 (s, 1H, NH) ppm (Fig. 15); 13C NMR
(100 MHz, DMSO-d6): d; 175.8 (C=S), 175.7 (C=O
Fig. 17 X-ray powder diffraction pattern of nanocrystalline MgO
Fig. 18 SEM micrograph of nanocrystalline MgO
Fig. 19 TEM micrograph of nanocrystalline MgO
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amide), 163.4, 161.0, 160.7, 160.6, 157.8, 157.4,
157.3, 154.2, 132.5, 130.0, 115.2 (C:N), 114.7,
100.4, 90.1 ppm (Fig. 16).
Results and discussion
The powder X-ray diffraction pattern of nanocrystalline
MgO is shown in Fig. 17. All the diffraction peaks matched
well with the face centered cubic structure of periclase
MgO (JCPDS No. 87-0653). The major peaks at 2h values
of 37.18, 43.08, 62.48, 74.88 and 78.68 can be indexed to the
lattice planes of (111), (200), (220), (311) and (222)
respectively.
The surface and textural morphology of the product was
studied by SEM analysis. A closer view reveals that most
of the nanocrystals have uniform diameter (Fig. 18).
The particle size was also examined using TEM. Fig-
ure 19 displays TEM micrographs of nanocrystalline MgO,
revealing that the particle size is approximately 50 nm.
From BET analysis, the specific surface area of
nanocrystalline MgO sample was found to be 63.32 m2/g. A
variety of pyrido[2,3-d]pyrimidines was prepared from
arylaldehydes, 6-aminouracil, 6-amino-2-thiouracil or
6-amino-1,3-dimethyluracil and malononitrile in the pres-
ence of nano-MgO in water at 80 C in excellent yields
(Table 1, entries 1–16). It is worth mentioning that the
corresponding pyrido[2,3-d]pyrimidines was isolated by
crystallization from the crude filtrate. The results have been
shown in Table 1. The reactions worked well with electron-
donating and electron-withdrawing aldehydes. This three-
component reaction proceeds via dual activation of sub-
strates by nanocrystalline MgO which have a number of
anionic oxidic Lewis basic O2-and Mg2? as Lewis acid site
[21]. The Lewis base moiety of the catalyst activates the
methylene group of malononitrile. The carbonyl oxygen of
aldehyde coordinates with the Lewis acid moiety increasing
the electrophilicity of the carbonyl carbon and thereby
making it possible to carry out the reaction in short time. In
a plausible mechanism, it is assumed that the reaction may
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R = H, Me
Aromatization
2+ 2- 2+ 2- 2+ 2- 2+
2- 2+ 2- 2+Scheme 2 A plausible
mechanism for the pyrido[2,3-
d]pyrimidines synthesis
Table 2 Recycling of nanocrystalline MgO for the preparation of 4a
Run 1 2 3 4 5
Yield (%)a 92 90 88 87 86
a All yields refer to isolated products
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between arylaldehyde and malononitrile to form interme-
diate I. Next, Michael addition of 6-aminouracils to inter-
mediate I affords II. Intermediate II converts to III after
tautomerization (nanocrystalline MgO can also act as a mild
base for the deprotonation of an acidic proton of Interme-
diate II). Then, Intermediate III converts to IV via cy-
clization. Next, intermediate IV converts to V after
tautomerization. Finally, the desired product VI is obtained
after aromatization from V (Scheme 2).
It is notable that the bulk MgO shows lower catalytic
activity than nanocrystalline MgO in this reaction and the
products were obtained with lower yields and longer time.
The high efficiency of the nanoparticle oxides is caused not
only by their high surface area but also by the high con-
centration of low-coordinated sites and structural defects
on their surface [22].
It is noteworthy to highlight that the nanocrystalline
MgO could be recovered and reused without a significant
loss of activity as illustrated in Table 2. After completion
of the reaction, the product was extracted with ethyl acetate
from the reaction mixture, and nanocrystalline MgO cata-
lyst was separated out by centrifugation and the recovered
catalyst was washed with ethanol followed by drying in an
oven at 100 C and reused as such for the subsequent re-
actions with fresh batch of reactants up to 5th run with only
a slight loss its activity.
Conclusions
We have developed a simple, clean, efficient and one-pot
procedure for the synthesis of pyrido[2,3-d]pyrimidines by
the three-component condensation of aromatic aldehyde,
6-aminouracil, 6-amino-2-thiouracil or 6-amino-1,3-
dimethyluracil andmalononitrile using nanocrystallineMgO
at 80 C in water as a green solvent. Simple performance and
work-up procedure and high yields are some of advantages of
this method. Also, nanocrystalline MgO is recyclable and
could be reused without significant loss of activity.
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